top of page
네트워킹

Directory

Discover detailed profiles of PoC companies.

c_logo_FUST-Lab.png

FUST Lab Co., Ltd.

Focused Ultrasonic Technology for Nano Dispersion and PFAS-Free Wastewater Treatment

ico_spe.png

Specialization

Ultrasonic Nano Dispersion Advanced Wastewater Treatment

ico_keyword.png

Keywords

Focused Ultrasonic

Microbubble Technology

ico_category.png

Category

Environmental Technology Industrial Water Treatment

ico_c_basic_info.png

Technology Introduction

Technology / Item Overview

  • FUST Lab (Focused Ultrasonic Technology Lab) pioneers focused ultrasonic energy systems for nano dispersion, non-biodegradable wastewater treatment, and PFAS degradation.

  • The company’s proprietary CAVITOX System applies microbubble cavitation to achieve incineration-free and chemical-free decomposition of persistent organic pollutants.

  • Offers a clean, sustainable alternative to ozone, UV, or peroxide-based oxidation processes (AOPs) — achieving over 99% degradation efficiency for pharmaceuticals and PFAS.

  • Enables both industrial wastewater reuse and zero-emission treatment aligned with global ESG and carbon-neutral mandates.

Owned Technology / Applied Products

(1) Owned Technology

  • Focused Ultrasonic Technology (KRISS-originated): Cylindrical ultrasonic transducer focusing energy precisely at the center for uniform nano dispersion.

  • Microbubble Cavitation Technology: Generates high-pressure (2,000 atm) implosions that destroy pollutant molecular bonds.
  • Advanced Oxidation Process (AOP) Enhancement: Optimized to break down non-biodegradable chemicals below 5 ppb, outperforming ozone, UV, and H₂O₂ systems.

  • Patents Registered / Granted:

    • Nano Dispersion Equipment & Process (KR + PCT)

    • Drug Delivery System using Focused Ultrasonic Technology

    • Non-biodegradable Material Degradation via Focused Ultrasound

    • Trademarks: DEBREX, CAVITOX


(2) Applied Products

  • CAVITOX System: Advanced microbubble oxidation device for PFAS and pharma wastewater.

  • DEBREX Platform: Ultrasonic nano dispersion solution for biomedical and nanomaterial industries.

  • Customized Ultrasonic Reactor Units: For industrial wastewater recycling and fine chemical applications.

D_Info_FUST-Lab_01.png

Development Needs & Value Proposition

(1) Problem Definition / Development Background

  • Traditional wastewater systems (filtration, ozonation, UV) fail to remove persistent toxins like PFAS and generate toxic byproducts.

  • Incineration of industrial wastewater emits large amounts of CO₂ and increases treatment costs.

(2) Value Proposition / Solution

  • CAVITOX delivers a chemical-free, incineration-free treatment system, reducing carbon emissions and energy costs by over 70%.

  • Achieves 99.9%+ degradation for APIs (Telmisartan, Sitagliptin) and PFAS compounds (PFOA, PFOS, PFOB).

  • Enables industrial wastewater reuse, reducing dependence on external water supply.

  • Applicable across semiconductors, pharmaceuticals, coatings, and battery manufacturing sectors.

Competitiveness

  • Technology Origin: Derived from KRISS (Korea Research Institute of Standards and Science) with verified Proof of Concept (POC).

  • Performance:

    • Degrades non-biodegradable toxins below 5 ppb.

    • Maintains efficiency without chemical oxidizers or filters.

  • Sustainability:

    • Zero incineration, no secondary waste, and CO₂-free operation.

    • Operable with renewable energy, reducing indirect emissions.

  • Certification & Recognition:

    • ISO 9001 / 14001 / 45001 certified.

    • Pre-Series A funded by Blue Point Partners, Enlight Ventures, IBK, and KDB (USD 2.6M).

Company Performance & Business Status

Key References

  • Research Institution No. 1542 (approved by KRISS).

  • Developed CAVITOX, a market-ready solution with global patent protection and pilot PoC results.

  • Collaborations with Hitachi Hightech Korea, Swedish AZ R&D Group, and Ecoset Korea for field deployments.

  • Preparing large-scale demo installations (Frankfurt, Sept 2025) for global commercialization

Overseas Experience

(1) PoC Progress

  • Completed real wastewater PoC showing >99% degradation of APIs and PFAS.

  • Verified zebrafish embryo toxicity test — LC₅₀ safe range achieved.

  • Field-tested CAVITOX AOP system for pharmaceutical and semiconductor wastewater.
     

(2) Global Expansion

  • Japan (2024):

    • Patent filings in progress for nano dispersion and PFAS oxidation technologies.

  • Europe (2025):

    • MoU signed (Nov 2024) → Contract (Apr 2025) → Sales Launch (May 2025).

    • Frankfurt demo facility setup planned for Sept 2025.

  • Global Market Focus: Advanced oxidation, PFAS removal, and ESG-aligned wastewater recycling sectors.

도시의 현대적인 인테리어 디자인

Please use the form below to start connecting with us.

Thanks for submitting!

bottom of page